文献速递糖尿病

非糖尿病范围内糖化血红蛋白升高与口服葡萄糖耐量试验同样预测1型糖尿病进展

Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests.
PubMed 文献 · Diabetes Care · 2022-01-01

在TEDDY前瞻性队列中,707名确认糖尿病相关自身抗体阳性的儿童被随访至糖尿病或中位年龄11.1岁,每季度测HbA1c。基线HbA1c相对升高10%可预测3期1型糖尿病风险(敏感性74%,特异性88%),多变量模型风险比HR 12.74(95%CI 8.7-18.6,P<0.0001),在TrialNet队列(n=1,190)中HR 5.09(95%CI 3.3-7.9,P<0.0001)。复合模型与OGTT 2小时血糖模型预测效能相似(TEDDY AUC 0.88 vs 0.85,TrialNet AUC 0.82)。

要点

  • 基线HbA1c相对升高≥10%可预测自身抗体阳性儿童进展至3期1型糖尿病。
  • HbA1c≥10%升高复合模型风险比在TEDDY为HR 12.74,在TrialNet为HR 5.09。
  • HbA1c复合模型预测效能与OGTT 2小时血糖复合模型相似。

核心结论

  • 基线HbA1c相对升高≥10%在预测携带遗传风险及糖尿病相关自身抗体的青少年进展至3期1型糖尿病风险方面,与OGTT 2小时血糖同样具有参考价值。

研究设计与样本

  • TEDDY前瞻性队列研究纳入707名确认糖尿病相关自身抗体阳性且至少两次HbA1c测量的儿童,随访至糖尿病或中位年龄11.1岁,确认抗体阳性后每季度测HbA1c。
  • 在TrialNet Pathway to Prevention研究中(n=1,190)对HbA1c方法进行验证。

主要发现

  • 基线HbA1c相对升高10%最佳标记TEDDY中3期1型糖尿病风险增加(敏感性74%,特异性88%)。
  • HbA1c变化风险的显著预测因素包括基线检测时年龄和HbA1c、遗传性别、自身抗体最大数量及至变化时HbA1c最大上升速率。
  • 包含HbA1c≥10%升高及其他因素的多变量模型显示TEDDY中3期风险增加(HR 12.74,95%CI 8.7-18.6,P<0.0001),TrialNet中亦增加(HR 5.09,95%CI 3.3-7.9,P<0.0001)。
  • 使用HbA1c≥10%升高的复合模型与OGTT 2小时血糖复合模型效能相似(TEDDY AUC分别为0.88和0.85),与TrialNet中HbA1c模型相似(AUC 0.82)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Biomarkers predicting risk of type 1 diabetes (stage 3) among children with islet autoantibodies are greatly needed to prevent diabetic ketoacidosis and facilitate prevention therapies. RESEARCH DESIGN AND METHODS: Children in the prospective The Environmental Determinants of Diabetes in the Young (TEDDY) study (n = 707) with confirmed diabetes-associated autoantibodies (GAD antibody, IA-2A, and/or insulin autoantibody) and two or more HbA1c measurements were followed to diabetes or median age 11.1 years. Once confirmed autoantibody positive, HbA1c was measured quarterly. Cox models and receiver operative characteristic curve analyses revealed the prognostic utility for risk of stage 3 on a relative HbA1c increase from the baseline visit or an oral glucose tolerance test (OGTT) 2-h plasma glucose (2-hPG). This HbA1c approach was then validated in the Type 1 Diabetes TrialNet Pathway to Prevention Study (TrialNet) (n = 1,190). RESULTS: A 10% relative HbA1c increase from baseline best marked the increased risk of stage 3 in TEDDY (74% sensitive; 88% specific). Significant predictors of risk for HbA1c change were age and HbA1c at the baseline test, genetic sex, maximum number of autoantibodies, and maximum rate of HbA1c increase by time of change. The multivariable model featuring a HbA1c ≥10% increase and these additional factors revealed increased risk of stage 3 in TEDDY (hazard ratio [HR] 12.74, 95% CI 8.7-18.6, P < 0.0001) and TrialNet (HR 5.09, 95% CI 3.3-7.9, P < 0.0001). Furthermore, the composite model using HbA1c ≥10% increase performed similarly to an OGTT 2-hPG composite model (TEDDY area under the curve [AUC] 0.88 and 0.85, respectively) and to the HbA1c model in TrialNet (AUC 0.82). CONCLUSIONS: An increase of ≥10% in HbA1c from baseline is as informative as OGTT 2-hPG in predicting risk of stage 3 in youth with genetic risk and diabetes-associated autoantibodies.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Vehik K, Boulware D, Killian M, et al. Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests. Diabetes Care. 2022. PMID: 36150054. doi:10.2337/dc22-0828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。